Application number | Title of the application | Filing Date | Status |
---|
08/519386 | MULTI-SUBTYPE FIV VACCINES | Aug 24, 1995 | Abandoned |
Array
(
[id] => 4126097
[patent_doc_number] => 06146628
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Biotherapeutic agents comprising recombinant PAP and PAP mutants'
[patent_app_type] => 1
[patent_app_number] => 8/501253
[patent_app_country] => US
[patent_app_date] => 1995-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29354
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/146/06146628.pdf
[firstpage_image] =>[orig_patent_app_number] => 501253
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/501253 | Biotherapeutic agents comprising recombinant PAP and PAP mutants | Jul 10, 1995 | Issued |
Array
(
[id] => 3781392
[patent_doc_number] => 05840313
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus'
[patent_app_type] => 1
[patent_app_number] => 8/493235
[patent_app_country] => US
[patent_app_date] => 1995-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13630
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840313.pdf
[firstpage_image] =>[orig_patent_app_number] => 493235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/493235 | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | Jun 19, 1995 | Issued |
Array
(
[id] => 3626366
[patent_doc_number] => 05686287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Marek\'s disease virus vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/502078
[patent_app_country] => US
[patent_app_date] => 1995-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686287.pdf
[firstpage_image] =>[orig_patent_app_number] => 502078
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/502078 | Marek's disease virus vaccine | Jun 13, 1995 | Issued |
Array
(
[id] => 4023841
[patent_doc_number] => 05993823
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Cytotoxic T lymphocyte-inducing lipopeptides and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/477420
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 20657
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/993/05993823.pdf
[firstpage_image] =>[orig_patent_app_number] => 477420
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477420 | Cytotoxic T lymphocyte-inducing lipopeptides and methods of use | Jun 6, 1995 | Issued |
Array
(
[id] => 3685359
[patent_doc_number] => 05695929
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Substitute saliva standard'
[patent_app_type] => 1
[patent_app_number] => 8/480790
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1887
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/695/05695929.pdf
[firstpage_image] =>[orig_patent_app_number] => 480790
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480790 | Substitute saliva standard | Jun 6, 1995 | Issued |
Array
(
[id] => 4020970
[patent_doc_number] => 05925513
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Diagnosis and treatment of AIDS onset'
[patent_app_type] => 1
[patent_app_number] => 8/488209
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15671
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925513.pdf
[firstpage_image] =>[orig_patent_app_number] => 488209
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488209 | Diagnosis and treatment of AIDS onset | Jun 6, 1995 | Issued |
Array
(
[id] => 4052541
[patent_doc_number] => 05863535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)'
[patent_app_type] => 1
[patent_app_number] => 8/476378
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 15981
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863535.pdf
[firstpage_image] =>[orig_patent_app_number] => 476378
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476378 | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Jun 6, 1995 | Issued |
Array
(
[id] => 4117345
[patent_doc_number] => 06046309
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)'
[patent_app_type] => 1
[patent_app_number] => 8/479366
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 15924
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046309.pdf
[firstpage_image] =>[orig_patent_app_number] => 479366
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479366 | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Jun 6, 1995 | Issued |
Array
(
[id] => 3723041
[patent_doc_number] => 05702707
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Diagnostic method and test kit for the serological detection of the AIDS virus'
[patent_app_type] => 1
[patent_app_number] => 8/476555
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14027
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702707.pdf
[firstpage_image] =>[orig_patent_app_number] => 476555
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476555 | Diagnostic method and test kit for the serological detection of the AIDS virus | Jun 6, 1995 | Issued |
Array
(
[id] => 3930902
[patent_doc_number] => 05928861
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'HTLV-I and HTLV-II peptide antigens and methods'
[patent_app_type] => 1
[patent_app_number] => 8/473702
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 12806
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928861.pdf
[firstpage_image] =>[orig_patent_app_number] => 473702
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473702 | HTLV-I and HTLV-II peptide antigens and methods | Jun 6, 1995 | Issued |
Array
(
[id] => 3887904
[patent_doc_number] => 05834267
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Method for producing a Gag-Env fusion protein'
[patent_app_type] => 1
[patent_app_number] => 8/487657
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13923
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834267.pdf
[firstpage_image] =>[orig_patent_app_number] => 487657
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487657 | Method for producing a Gag-Env fusion protein | Jun 6, 1995 | Issued |
08/481957 | TREATMENT OF HIV AND OTHER VIRAL INFECTIONS USING COMBINATORIAL THERAPY | Jun 6, 1995 | Abandoned |
08/488435 | TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4080451
[patent_doc_number] => 06024964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Membrane anchor/active compound conjugate, its preparation and its uses'
[patent_app_type] => 1
[patent_app_number] => 8/466695
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 17956
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/024/06024964.pdf
[firstpage_image] =>[orig_patent_app_number] => 466695
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466695 | Membrane anchor/active compound conjugate, its preparation and its uses | Jun 5, 1995 | Issued |
Array
(
[id] => 4229729
[patent_doc_number] => 06074650
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-13
[patent_title] => 'Membrane anchor/active compound conjugate, its preparation and its uses'
[patent_app_type] => 1
[patent_app_number] => 8/465709
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 18031
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/074/06074650.pdf
[firstpage_image] =>[orig_patent_app_number] => 465709
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465709 | Membrane anchor/active compound conjugate, its preparation and its uses | Jun 5, 1995 | Issued |
Array
(
[id] => 3920756
[patent_doc_number] => 05951986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Tandem synthetic HIV-1 peptides'
[patent_app_type] => 1
[patent_app_number] => 8/467881
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18304
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 532
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/951/05951986.pdf
[firstpage_image] =>[orig_patent_app_number] => 467881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467881 | Tandem synthetic HIV-1 peptides | Jun 5, 1995 | Issued |
Array
(
[id] => 4280742
[patent_doc_number] => 06210684
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Method for delaying the onset of AIDS'
[patent_app_type] => 1
[patent_app_number] => 8/442298
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1795
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/210/06210684.pdf
[firstpage_image] =>[orig_patent_app_number] => 442298
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442298 | Method for delaying the onset of AIDS | May 15, 1995 | Issued |
08/387932 | RETRO-, INVERSO- AND RETRO-INVERSO SYNTHETIC PEPTIDE ANALOGUES | Apr 23, 1995 | Abandoned |
Array
(
[id] => 4067873
[patent_doc_number] => 05965135
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'HIV-1 virus isolates of a subtype and its differential diagnostics'
[patent_app_type] => 1
[patent_app_number] => 8/392806
[patent_app_country] => US
[patent_app_date] => 1995-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10398
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965135.pdf
[firstpage_image] =>[orig_patent_app_number] => 392806
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392806 | HIV-1 virus isolates of a subtype and its differential diagnostics | Apr 19, 1995 | Issued |